PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

32 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Birkenfeld, A.L. ; Bergman, M.* & Stefan, N.*: Tirzepatide for obesity treatment and diabetes prevention. N. Engl. J. Med. 392, 2491-2492 (2025)
2.
Garvey, W.T.* et al.: Coadministered cagrilintide and semaglutide in adults with overweight or obesity. N. Engl. J. Med., DOI: 10.1056/NEJMoa2502081 (2025)
3.
Global Cardiovascular Risk Consortium (Peters, A.) & Global Cardiovascular Risk Consortium (Thorand, B.): Global effect of cardiovascular risk factors on lifetime estimates. N. Engl. J. Med., DOI: 10.1056/NEJMoa2415879 (2025)
4.
Krischer, J.P.* et al.: SARS-CoV-2 - no increased islet autoimmunity or type 1 diabetes in teens. N. Engl. J. Med. 389, 474-475 (2023)
5.
Magnussen, C.* et al.: Global effect of modifiable risk factors on cardiovascular disease and mortality. N. Engl. J. Med. 389, 1273-1285 (2023)
6.
Anker, S.D.* et al.: Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 385, 1451-1461 (2021)
7.
Pitt, B.* et al.: Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N. Engl. J. Med. 385, 2252-2263 (2021)
8.
von Mutius, E. & Martinez, F.D.*: Vitamin D supplementation during pregnancy and the prevention of childhood asthma. N. Engl. J. Med. 382, 574-575 (2020)
9.
Husain, M.* et al.: Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 381, 841-851 (2019)
10.
Körner, A.* ; Tschöp, M.H. & Blüher, M.*: Five-year outcomes of gastric bypass in adolescents as compared with adults. N. Engl. J. Med. 381:e17 (2019)
11.
Neumann, J.T.* et al.: Application of high-sensitivity troponin in suspected myocardial infarction. N. Engl. J. Med. 380, 2529-2540 (2019)
12.
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134-1144 (2016)
13.
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease (vol 374, pg 1134, 2016). N. Engl. J. Med. 374, 1898-1898 (2016)
14.
Claussnitzer, M. et al.: FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373, 895-907 (2015)
15.
Nelson, C.P.* et al.: Genetically determined height and coronary artery disease. N. Engl. J. Med. 372, 1608-1618 (2015)
16.
Beuschlein, F.* et al.: Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019-1028 (2014)
17.
TG and HDL Working Group (Crosby, J.R.* ; Peloso, G.M.* ; Auer, P.L.* ; Peters, A. ; Reiner, A.P.* ; Boerwinkle, E.* ; Kathiresan, S.*): Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22-31 (2014)
18.
Liu, E. et al.: Risk of pediatric celiac disease according to HLA haplotype and country. N. Engl. J. Med. 371, 42-49 (2014)
19.
Navon Elkan, P.* et al.: Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N. Engl. J. Med. 370, 921-931 (2014)
20.
Stand, E.: Saxagliptin, alogliptin, and cardiovascular outcomes. N. Engl. J. Med. 370, 483-484 (2014)